Neusoft, Lianying and Mingfeng launched high-end PET-CT: breaking the import monopoly of GPS

In 2016, it was an extraordinary year for China's medical device industry. Neusoft, Lianying and Mingfeng, three domestic medical device enterprises, successively launched high-end medical device PET-CT, breaking the situation that China's high-end medical device market has been monopolized by imported products for a long time, and the cost of high-end medical device testing will also plummet. This undoubtedly gives a big blow to the multinational enterprises which occupy the high-end medical device market in China.
&The biggest significance is that imported PET-CT needs tens of millions, while domestic PET-CT only needs about 10 million. The inspection cost of imported equipment is about 7000, and all of them are at their own expense, while that of domestic equipment is half of it. &Ming Feng medical equipment company Huang Xin told reporters.
Neusoft, Lianying and Mingfeng launched high-end PET-CT: breaking the import monopoly of GPS
Long term absence of Chinese brands
The pain of China's medical device industry is the loss of position in the field of high-end medical devices. For a long time, MRI, CT, PET-CT and other highly technology intensive equipment have been almost monopolized by three multinational enterprises, Ge, Philips and Siemens. These three multinational enterprises monopolize 90% of China's high-end medical equipment, while domestic equipment accounts for less than 10%. In the field of PET-CT, domestic hospitals are 100% dependent on imports, and the sales price and maintenance cost are very high.
As an important instrument of the country, the long-term absence of Chinese brands in the field of high-end medical devices has brought certain challenges to the implementation of the national policy of healthy China. At the National Conference on science and technology innovation, state leaders stressed that high-end medical equipment mainly depends on imports, which is one of the main reasons why it is expensive to see a doctor. ”
In order to improve the health level of the whole people and promote the construction of healthy China, a new leap must be made in the development of science and technology in the key driving field of medical devices. However, due to the weak innovation ability and industrial foundation, the level of independent guarantee of medical equipment in China is not high.
&"Compared with the developed countries, the overall technical level of medical devices in China still has a gap of about 10 years. If we do not speed up the innovation and development of medical devices, it will be difficult to catch up with the overall technical level of medical devices in developed countries in the next 10-15 years. Some of the cutting-edge technologies are hard to change. &"Wang Baoting, former director of the medical device supervision department of the State Food and drug administration, told reporters.
At present, the medical device industry is in rapid development, with an average annual growth rate of about 20% in market scale, which is higher than that of medicine and traditional Chinese medicine. In 2001, the sales scale of China's medical device market was only 17.9 billion yuan. In 2016, the scale of China's medical device market is between 400 billion yuan and 500 billion yuan. It is estimated that by 2020, the scale of China's medical device market will exceed 600 billion yuan.
&In 2014, the proportion of global consumption of medicine and medical devices was about 1:0.7. Developed countries such as Europe, America and Japan had reached 1:1.02, while China had only 1:0.19. Faced with such a large market space, a large number of domestic medical devices can only find a way under the secondary hospital, and lose a place in the high-end market.